Annex Advisory Services, LLC Bristol Myers Squibb CO Transaction History

Annex Advisory Services, LLC

$2.88 Billion
Q1 2025

A detailed history of Annex Advisory Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Annex Advisory Services, LLC holds 5,945 shares of BMY stock, worth $279,415. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,945

Previous 6,796 12.52%

Holding current value

$279,415

Previous $384,000 5.73%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	SELL	$53.9 - $63.11 $45,868 - $53,706	-851 Reduced 12.52%	5,945 $362,000
Q4 2024 Jan 16, 2025	BUY	$51.92 - $59.94 $19,937 - $23,016	384 Added 5.99%	6,796 $384,000
Q3 2024 Oct 10, 2024	BUY	$39.66 - $51.75 $4,600 - $6,003	116 Added 1.84%	6,412 $331,000
Q2 2024 Jul 12, 2024	SELL	$40.25 - $52.99 $24,552 - $32,323	-610 Reduced 8.83%	6,296 $261,000
Q1 2024 Apr 12, 2024	SELL	$47.98 - $54.4 $167,594 - $190,019	-3,493 Reduced 33.59%	6,906 $374,000
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $5.08 Million - $6.06 Million	-104,838 Reduced 90.98%	10,399 $533,000
Q3 2023 Oct 31, 2023	BUY	$57.89 - $64.73 $29,523 - $33,012	510 Added 0.44%	115,237 $6.69 Million
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $96,584 - $107,241	-1,516 Reduced 1.3%	114,727 $7.34 Million
Q1 2023 Apr 27, 2023	BUY	$65.71 - $74.53 $2.51 Million - $2.84 Million	38,158 Added 48.87%	116,243 $8.06 Million
Q4 2022 Jan 27, 2023	BUY	$68.48 - $81.09 $79,779 - $94,469	1,165 Added 1.51%	78,085 $5.62 Million
Q3 2022 Oct 24, 2022	SELL	$0.13 - $76.84 $316 - $186,874	-2,432 Reduced 3.06%	76,920 $5.47 Million
Q2 2022 Jul 27, 2022	SELL	$72.62 - $79.98 $22,076 - $24,313	-304 Reduced 0.38%	79,352 $6.11 Million
Q1 2022 Apr 13, 2022	BUY	$61.48 - $73.72 $274,692 - $329,380	4,468 Added 5.94%	79,656 $5.82 Million
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $402,654 - $469,400	7,508 Added 11.09%	75,188 $4.69 Million
Q3 2021 Oct 18, 2021	BUY	$59.17 - $69.31 $266,501 - $312,172	4,504 Added 7.13%	67,680 $4 Million
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $218,666 - $238,127	3,532 Added 5.92%	63,176 $4.22 Million
Q1 2021 Apr 22, 2021	BUY	$59.34 - $66.74 $320,851 - $360,863	5,407 Added 9.97%	59,644 $3.77 Million
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $273,225 - $309,614	4,732 Added 9.56%	54,237 $3.36 Million
Q3 2020 Oct 23, 2020	SELL	$57.43 - $63.64 $5,455 - $6,045	-95 Reduced 0.19%	49,505 $2.99 Million
Q2 2020 Jul 21, 2020	BUY	$54.82 - $64.09 $219,444 - $256,552	4,003 Added 8.78%	49,600 $2.92 Million
Q1 2020 Apr 22, 2020	BUY	$46.4 - $67.43 $263,737 - $383,272	5,684 Added 14.24%	45,597 $2.54 Million
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $16 Million - $20.8 Million	-324,330 Reduced 89.04%	39,913 $2.56 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $16.6 Million - $21.6 Million	337,230 Added 1248.4%	364,243 $7.37 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $1.16 Million - $1.37 Million	27,013 New	27,013 $1.37 Million

Others Institutions Holding BMY

# of Institutions

2,806

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.9B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Annex Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annex Advisory Services, LLC with notifications on news.

Account

Annex Advisory Services, LLC Bristol Myers Squibb CO Transaction History